CROI 2017 ARV Drug Updates

CROI 2017 ARV Drug Updates

Wednesday, May 17, 2017
AETC National Coordinating Resource Center

RWC Susa Coffey Image

Study results on four new antiretroviral drug regimens, presented at CROI 2017, have been summarized by the AETC National Coordinating Resource Center (NCCC).  The following summaries are by NCCC's Susa Coffey, MD and are presented in ShareSpot: The AETC Blog.

  • CROI 2017: Doravirine Noninferior to Darunavir + Ritonavir in Initial Treatment
  • CROI 2017: Bictegravir and Dolutegravir, Head-to-Head Comparison
  • CROI 2017: Dolutegravir in 2-Drug Simplification Studies
  • CROI 2017: Failure of Dolutegravir Monotherapy